Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ZLTQ's Cash to Debt is ranked higher than
80% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 6.28 vs. ZLTQ: No Debt )
ZLTQ' s 10-Year Cash to Debt Range
Min: 0.4   Max: No Debt
Current: No Debt

Equity to Asset 0.71
ZLTQ's Equity to Asset is ranked higher than
73% of the 358 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. ZLTQ: 0.71 )
ZLTQ' s 10-Year Equity to Asset Range
Min: -9.69   Max: 0.89
Current: 0.71

-9.69
0.89
Interest Coverage No Debt
ZLTQ's Interest Coverage is ranked higher than
79% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 205.72 vs. ZLTQ: No Debt )
ZLTQ' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 4
Z-Score: 14.70
M-Score: -3.10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -17.33
ZLTQ's Operating margin (%) is ranked higher than
50% of the 363 Companies
in the Global Medical Devices industry.

( Industry Median: 6.75 vs. ZLTQ: -17.33 )
ZLTQ' s 10-Year Operating margin (%) Range
Min: -1082.23   Max: -12.76
Current: -17.33

-1082.23
-12.76
Net-margin (%) -17.29
ZLTQ's Net-margin (%) is ranked higher than
51% of the 363 Companies
in the Global Medical Devices industry.

( Industry Median: 5.06 vs. ZLTQ: -17.29 )
ZLTQ' s 10-Year Net-margin (%) Range
Min: -1111.78   Max: -14.09
Current: -17.29

-1111.78
-14.09
ROE (%) -30.85
ZLTQ's ROE (%) is ranked lower than
51% of the 363 Companies
in the Global Medical Devices industry.

( Industry Median: 5.79 vs. ZLTQ: -30.85 )
ZLTQ' s 10-Year ROE (%) Range
Min: -41.53   Max: -10.18
Current: -30.85

-41.53
-10.18
ROA (%) -21.92
ZLTQ's ROA (%) is ranked lower than
51% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. ZLTQ: -21.92 )
ZLTQ' s 10-Year ROA (%) Range
Min: -254.68   Max: -9.06
Current: -21.92

-254.68
-9.06
ROC (Joel Greenblatt) (%) -896.57
ZLTQ's ROC (Joel Greenblatt) (%) is ranked lower than
57% of the 376 Companies
in the Global Medical Devices industry.

( Industry Median: 12.75 vs. ZLTQ: -896.57 )
ZLTQ' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1431.25   Max: -330.43
Current: -896.57

-1431.25
-330.43
» ZLTQ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

ZLTQ Guru Trades in Q1 2013

Chuck Royce 765,000 sh (-15%)
» More
Q2 2013

ZLTQ Guru Trades in Q2 2013

Chuck Royce 765,000 sh (unchged)
» More
Q3 2013

ZLTQ Guru Trades in Q3 2013

Chuck Royce 553,200 sh (-27.69%)
» More
Q4 2013

ZLTQ Guru Trades in Q4 2013

RS Investment Management 978,900 sh (New)
Jim Simons 364,357 sh (New)
Chuck Royce 410,200 sh (-25.85%)
» More
» Details

Insider Trades

Latest Guru Trades with ZLTQ



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 10.59
ZLTQ's P/B is ranked lower than
74% of the 355 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. ZLTQ: 10.59 )
ZLTQ' s 10-Year P/B Range
Min: 1.79   Max: 13.07
Current: 10.59

1.79
13.07
P/S 5.81
ZLTQ's P/S is ranked lower than
71% of the 378 Companies
in the Global Medical Devices industry.

( Industry Median: 2.80 vs. ZLTQ: 5.81 )
ZLTQ' s 10-Year P/S Range
Min: 0.17   Max: 7.17
Current: 5.81

0.17
7.17
EV-to-EBIT -32.12
ZLTQ's EV-to-EBIT is ranked higher than
89% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 20.80 vs. ZLTQ: -32.12 )
ZLTQ' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -32.12

Valuation & Return

vs
industry
vs
history
Price/Net Cash 34.43
ZLTQ's Price/Net Cash is ranked lower than
68% of the 117 Companies
in the Global Medical Devices industry.

( Industry Median: 13.75 vs. ZLTQ: 34.43 )
ZLTQ' s 10-Year Price/Net Cash Range
Min: 5.36   Max: 36.37
Current: 34.43

5.36
36.37
Price/Net Current Asset Value 21.31
ZLTQ's Price/Net Current Asset Value is ranked lower than
68% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: 8.80 vs. ZLTQ: 21.31 )
ZLTQ' s 10-Year Price/Net Current Asset Value Range
Min: 4.33   Max: 22.51
Current: 21.31

4.33
22.51
Price/Tangible Book 11.85
ZLTQ's Price/Tangible Book is ranked lower than
77% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. ZLTQ: 11.85 )
ZLTQ' s 10-Year Price/Tangible Book Range
Min: 2.54   Max: 12.52
Current: 11.85

2.54
12.52
Price/Median PS Value 2.81
ZLTQ's Price/Median PS Value is ranked lower than
76% of the 334 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. ZLTQ: 2.81 )
ZLTQ' s 10-Year Price/Median PS Value Range
Min: 0.19   Max: 2.97
Current: 2.81

0.19
2.97

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
ZELTIQ Aesthetics Inc is a medical technology company. It develops and commercializes medical products such as 'CoolSculpting System' which is a non-invasive product for the selective reduction of body fat.
» More Articles for ZLTQ

Headlines

Articles On GuruFocus.com
4 Stocks To Buy, 1 To Avoid In 2012 Feb 18 2012 
Weekly CFO Sales Highlight: INFA, DHR, AN, SMTC, ZLTQ Oct 31 2011 

More From Our Partners
Morning Market Movers Apr 14 2014 - BENZINGA

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide